drugset
drugset / Trial / NCT04033458

A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants

NCT04033458 ↗

Phase 1 Terminated 1 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to compare the pharmacokinetic profile of a single dose of two solid dosage formulations relative to a reference formulation (solution in polyethylene glycol-400 \[PEG-400\]) of JNJ-64140284 in healthy male participants under fasting condition and to assess the effect of food on the bioavailability of two solid dosage formulations of JNJ-64140284.

Timeline

Start
2019-07-29
Primary completion
2019-08-01
Completion
2019-08-01

Outcome

Outcome not reported

Stopped (Business): “stopped because of a business decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-64140284 Unknown — Oral

Indications

No indication recorded.